Researchers Show How SARS-COV-2 Spike Protein Causes Acute Lung Injury in Mice

Will the vaccine continue to make spike proteins?

Dr. Been says:

"SARS-COV-2 mutates every day. If you go to NextStrain.org, you will see that there are thousands of mutations. Question is, is it mutating at the spike protein? Fortunately because it uses the spike protein as a hand to bind with us, it has to keep that part constant. And we are attacking that part. We are neutralizing it by attacking the spike protein. Because of that, the vaccines are successful."

Just a note: Hydroxychloroquine also "attacks" the spike protein, just in a different way. It immobilizes the spike protein, by changing the pH of your endosomes, making the spike protein unable to bind to your cells.

So, hydroxychloroquine works, but it's just a lot faster, way less complicated, and infinitely less risky.

"It does mutate, but spike protein stays constant."

I really like Dr. Mobeen, partly becasue he does TONS of research and tends not to state anything as definitive fact - he seems to be open to the idea that he could have missed something in his research, but he tries to give the best conclusions based on the research he has been able to find. Now THAT is a true Scientist

The fact is, NOBODY knows what will happen with the vaccines, or how effective they will be. Dr. Mobeen said the spike protein remains constant, and that's why the vaccines can continue to work against it... but this was last year, and now we've seen that the spike protein DOES CHANGE.

This is the website Dr. Mobeen refers to:

Nextstrain

Real-time tracking of pathogen evolution

Nextstrain is an open-source project to harness the scientific and public health potential of pathogen genome data. We provide a continually-updated view of publicly available data alongside powerful analytic and visualization tools for use by the community. Our goal is to aid epidemiological understanding and improve outbreak response. If you have any questions, or simply want to say hi, please give us a shout at hello@nextstrain.org.

SARS-CoV-2 (COVID-19)

We are incorporating SARS-CoV-2 genomes as soon as they are shared and providing analyses and situation reports. In addition we have developed a number of resources and tools, and are facilitating independent groups to run their own analyses.

Latest global analysis - GISAID data

Latest global analysis - open data

Nextstrain Groups

We want to enable research labs, public health entities and others to share their datasets and narratives through Nextstrain with complete control of their data and audience.

neherlab

spheres

Explore pathogens

Genomic analyses of specific pathogens kept up-to-date by the Nextstrain team.

Seasonal influenza